Company Filing History:
Years Active: 2016-2018
Title: Innovations and Contributions of Robert H E Friesen
Introduction
Robert H E Friesen is a notable inventor based in Leiden, Netherlands. He has made significant contributions to the field of vaccine development, particularly in relation to influenza. With a total of five patents to his name, Friesen's work has had a substantial impact on public health.
Latest Patents
Friesen's latest patents include innovative approaches to influenza virus vaccines. One of his patents focuses on influenza hemagglutinin stem domain polypeptides. This invention provides a method for creating polypeptides that can be used in the detection, prevention, and treatment of influenza. Another significant patent describes human binding molecules capable of neutralizing the influenza virus H3N2. These binding molecules, which include human monoclonal antibodies, have broad neutralizing activity and can potentially provide cross-subtype protection against various influenza strains.
Career Highlights
Throughout his career, Friesen has worked with prominent companies in the vaccine industry. He has been associated with Janssen Vaccines & Prevention B.V. and Crucell Holland B.V. His work in these organizations has contributed to advancements in vaccine technology and public health initiatives.
Collaborations
Friesen has collaborated with notable colleagues, including Ronald Vogels and Jan Willem Meijberg. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the impact of his inventions.
Conclusion
Robert H E Friesen's contributions to vaccine development, particularly in the area of influenza, demonstrate his commitment to improving global health. His innovative patents and collaborations highlight the importance of research and development in combating infectious diseases.